I think something that will really benefit NNSR in regards to DKL, and that is their patents, and the direct link to the specific patent attorney's DKL uses.
It seems through my DD that NNSR has yet to build a patent portfolio [mainly do to cash?], so outside other outstanding reasons for acquiring DKL, this is significant.
I'm sure there are many company under the radar screen developing nano e-coli detectors, so the sooner NNSR applies for protection, and makes it public, the better I will feel about my investment.
Temp'
News 
Market Data 
Discover 
